NCT00736528View on ClinicalTrials.gov

A Phase I, Multiple Dose Study of PF-04447943 in Healthy Elderly Volunteers

PHASE1TerminatedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions

HealthyElderly

Interventions

DRUG

PF-04447943

05 mg BID for 14 days

DRUG

PF-04447943

15 mg BID for 14 days

DRUG

PF-04447943

45mg BID for 14 days

DRUG

Placebo

Placebo for 14 days

Trial Locations (1)

32608

Pfizer Investigational Site, Gainesville

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY